Stock 688089 CABIO BIOTECH (WUHAN) CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Company Cabio Biotech (Wuhan) Co., Ltd.

Equities

688089

CNE100005X31

Food Processing

End-of-day quote Shanghai S.E.
Other stock markets
 03:30:00 24/05/2024 am IST 		5-day change 1st Jan Change
15.84 CNY -0.88% Intraday chart for Cabio Biotech (Wuhan) Co., Ltd. -5.49% -11.51%
30/04 Mainland China stocks edge lower ahead of long Labor Day holiday, Hong Kong rises RE
26/04 Cabio Biotech Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

Business Summary

Cabio Biotech Wuhan Co Ltd is a China-based company principally engaged in biotechnology business. The Company is mainly engaged in the research and development, production and sales of polyunsaturated fatty acids arachidonic acid (ARA), algal oil docosahexaenoic acid (DHA) and sialic acid (SA), and natural beta-carotene products. Its products are mainly used in infant formula food, dietary supplements, nutritional health food and formula food for special medical purposes. The Company integrates industrial strain-oriented optimization technology, fermentation fine control technology, and efficient separation, purification and preparation technology, and provides nutrient products and innovative solutions for customers in the global nutrition and health field through sustainable microbial synthesis and manufacturing methods. The Company mainly conducts its business in domestic and overseas markets.

Number of employees: 444

Sales per Business

CNY in Million2022Weight2023Weight Delta
Arachidonic Acid
73.1 %
256 66.2 % 302 73.1 % +18.22%
Docosahexaenoic Acid
19.2 %
65 16.7 % 79 19.2 % +23.09%
Sialic Acid
5.6 %
34 8.9 % 23 5.6 % -32.60%
Other Business
2.0 %
31 8.1 % 8 2.0 % -73.16%

Sales per region

CNY in Million2022Weight2023Weight Delta
China
62.3 %
231 57.6 % 271 62.3 % +17.17%
Overseas
37.7 %
171 42.4 % 164 37.7 % -3.77%

Managers

Managers TitleAgeSince
De Wei Yi CEO
 Chief Executive Officer 59 22/04/22
Hua Biao Wang DFI
 Director of Finance/CFO 59 22/04/22
Zhi Ming Wang CTO
 Chief Tech/Sci/R&D Officer 55 22/04/22
Bin Du BRD
 Director/Board Member 59 22/04/22
Fang Wang IRC
 Investor Relations Contact 34 01/20/01
Xiang Yu Li PRN
 Corporate Officer/Principal 46 27/21/27
Hua Rong Yi SEC
 Corporate Secretary 48 29/21/29

Members of the board

Members of the board TitleAgeSince
Yi fei Wang BRD
 Director/Board Member 43 27/21/27
De Wei Yi CEO
 Chief Executive Officer 59 22/04/22
Qi Liu BRD
 Director/Board Member 47 27/21/27
Bin Du BRD
 Director/Board Member 59 22/04/22
Hua Biao Wang DFI
 Director of Finance/CFO 59 22/04/22
Yu Jun Wu BRD
 Director/Board Member 39 01/15/01
Zhi Ming Wang CTO
 Chief Tech/Sci/R&D Officer 55 22/04/22
Xiang Dong Chen BRD
 Director/Board Member 61 27/21/27
Chun Li BRD
 Director/Board Member 54 27/21/27
Jing Chen BRD
 Director/Board Member 41 27/21/27

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 168,309,120 84,114,414 ( 49.98 %) 0 49.98 %

Shareholders

NameEquities%Valuation
De Wei Yi
45.55 %
76,671,377 45.55 % 208 M ¥
First Seafront Fund Management Co., Ltd.
1.722 %
2,898,481 1.722 % 8 M ¥
Huashang Fund Management Co., Ltd.
1.621 %
2,727,824 1.621 % 7 M ¥
Beijing Fenghui Investment Management Co. Ltd.
0.9815 %
1,652,000 0.9815 % 4 M ¥
Guo Yong Liu
0.9234 %
1,554,108 0.9234 % 4 M ¥
UBS Asset Management Switzerland AG
0.8734 %
1,470,000 0.8734 % 4 M ¥
Zhong Ou Asset Management Co., Ltd
0.8318 %
1,400,000 0.8318 % 4 M ¥
China Asset Management Co., Ltd.
0.7354 %
1,237,788 0.7354 % 3 M ¥
Hua Biao Wang
0.6462 %
1,087,565 0.6462 % 3 M ¥
Jian Guo Zhou
0.6239 %
1,050,000 0.6239 % 3 M ¥

Company contact information

Cabio Biotech (Wuhan) Co., Ltd.

999 Gaoxin Avenue East Lake New Technology Dev Zone

430075, Wuhan

+

http://www.cabio.cn
address Cabio Biotech (Wuhan) Co., Ltd.(688089)

Sector

Consumer Non-Cyclicals
Food & Beverages
Food & Tobacco
Food Processing
Special Foods & Wellbeing Products

Sales per Business

Sales per region

Ratings for Cabio Biotech (Wuhan) Co., Ltd.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
15.84 CNY
Average target price
18.5 CNY
Spread / Average Target
+16.79%
Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Special Foods & Wellbeing Products

1st Jan change Capi.
CABIO BIOTECH (WUHAN) CO., LTD. Stock Cabio Biotech (Wuhan) Co., Ltd.
-11.51% 37Cr
ZHEJIANG NHU COMPANY LTD. Stock Zhejiang NHU Company Ltd.
+13.97% 828.41Cr
BELLRING BRANDS, INC. Stock BellRing Brands, Inc.
+3.37% 770.73Cr
CSPC INNOVATION PHARMACEUTICAL CO., LTD. Stock CSPC Innovation Pharmaceutical Co., Ltd.
+0.60% 600.47Cr
THE SIMPLY GOOD FOODS COMPANY Stock The Simply Good Foods Company
-6.04% 371.16Cr
BYHEALTH CO., LTD Stock Byhealth Co., Ltd
-10.75% 360.5Cr
XIAMEN KINGDOMWAY GROUP COMPANY Stock Xiamen Kingdomway Group Company
-7.53% 128.52Cr
HERBALIFE LTD. Stock Herbalife Ltd.
-29.55% 108.56Cr
SIRIO PHARMA CO., LTD. Stock Sirio Pharma Co., Ltd.
+14.57% 99Cr
USANA HEALTH SCIENCES, INC. Stock USANA Health Sciences, Inc.
-12.85% 91Cr
Special Foods & Wellbeing Products
  1. Stock Market
  2. Equities
  3. 688089 Stock
  4. Company Cabio Biotech (Wuhan) Co., Ltd.